1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Cameroon Pharmaceuticals and Healthcare Report Q3 2016

Cameroon Pharmaceuticals and Healthcare Report Q3 2016

  • May 2016
  • -
  • Business Monitor International
  • -
  • 50 pages

Includes 3 FREE quarterly updates

BMI View: Although Cameroon's economic growth is expected to remain on track driven by public-privatepartnerships in strategic infrastructure projects, the country's pharmaceutical and healthcare sector willremain dependent on private out-of-pocket spending and global aid funds, which will weigh on the sector'spotential over the forecast period. That said, international efforts to implement universal health coverage,as well as local initiatives in e-health and health coverage arrangements, will contribute in supporting thehealthcare sector development and gradually improve access to treatment.

Headline Expenditure Projections

- Pharmaceuticals: XAF217.14bn (USD360mn) in 2015 to XAF238.26bn (USD390mn) in 2016; +9.7%in local currency terms and +6.7% in US dollar terms. Forecast revised downwards from last quarter.

- Healthcare: XAF694.42bn (USD1.16bn) in 2015 to XAF728.06bn (USD1.19bn) in 2016; +4.9% in localcurrency terms and +2.0% in US dollar terms. Forecast revised downwards from last quarter.

Table Of Contents

Cameroon Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Cameroon 2014-2020) 7
SWOT 9
Industry Forecast 10
Pharmaceutical Market Forecast 10
Table: Pharmaceutical Sales, Historical Data And Forecasts (Cameroon 2012-2020) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Cameroon 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Cameroon 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Cameroon 2012-2020) 18
Industry Risk Reward Index 19
Middle East and Africa Risk/Reward Index - Q3 2016 19
Cameroon Risk/Reward Index 27
Rewards 27
Risks 27
Regulatory Review 29
Market Overview 31
Healthcare Sector 32
Epidemiology 33
Competitive Landscape 36
Research-Based Industry 36
Table: Multinational Market Activity 38
Demographic Forecast 39
Table: Population Headline Indicators (Cameroon 1990-2025) 40
Table: Key Population Ratios (Cameroon 1990-2025) 40
Table: Urban/Rural Population and Life Expectancy (Cameroon 1990-2025) 41
Table: Population By Age Group (Cameroon 1990-2025) 41
Table: Population By Age Group % (Cameroon 1990-2025) 42
Glossary 44
Methodology 46
Pharmaceutical Expenditure Forecast Model 46
Healthcare Expenditure Forecast Model 46
Notes On Methodology 47
Risk/Reward Index Methodology 48
Index Overview 49
Table: Pharmaceutical Risk/Reward Index Indicators 49
Indicator Weightings 50

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Opportunity in the Indian Pharmaceutical Market - 2016; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Opportunity in the Indian Pharmaceutical Market - 2016; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

  • $ 5 750
  • Industry report
  • April 2016
  • by Feedback Business Consulting

This report provides an insight into the Indian Pharmaceutical current market scenario, structure and practices. In depth market scenario includes; - Current market size estimates, including domestic market, ...

Omega 3 PUFA Market: Type (DHA (docosahexaenoic acid), EPA (eicosapentaenoic acid), ALA (Alpha-linoleic acid)) Source (Marine, Plant) Form (Oils, Capsules, Powder) Application (Dietary Supplements, Pharmaceuticals, Infant Foods, F&B)-Forecast(2015-2020)

Omega 3 PUFA Market: Type (DHA (docosahexaenoic acid), EPA (eicosapentaenoic acid), ALA (Alpha-linoleic acid)) Source (Marine, Plant) Form (Oils, Capsules, Powder) Application (Dietary Supplements, Pharmaceuticals, Infant Foods, F&B)-Forecast(2015-2020)

  • $ 5 250
  • Industry report
  • February 2016
  • by Industry ARC

Omega-3 fatty acids are polyunsaturated fatty acids which have potential health benefits and are essential for increasing metabolic rate. Omega-3 PUFA ingredients are used to manufacture products that ...

Opportunity in the Indian Anti-Diabetic Pharmaceuticals Market - 2016; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Opportunity in the Indian Anti-Diabetic Pharmaceuticals Market - 2016; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

  • $ 5 000
  • Industry report
  • April 2016
  • by Feedback Business Consulting

This report provides an insight into the Indian Anti-Diabetic Pharmaceuticals current market scenario, structure and practices. In depth market scenario includes; - Current market size estimate - Market ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.